ARCHIVES

AACR Membership Up 14 Percent Per Year Since ‘88

This article is from The Cancer Letter archive.

Vol. 16 No. 23 | June 8, 1990

Download PDF Visit The Full Archive

Related Articles

Bioassay Program To NIEHS” NCI Denies Rumor

March 31, 1978

Letter: No Intent To Link Flags With NSABP Inquiry, ORI’s Bivens Writes

March 10, 1995

Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman

April 1, 1994

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

Katterhagen Predicts Increase Support From State, Local sources, Sees It As Community Challenge

March 27, 1981

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007